← Leaderboards
Antu Dey
International Aids Vaccine Initiative
$7,016,884
Attributed
$7,016,884
Total exposure
1
Grants
1
Lead (contact PI)
Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants. They are the sole PI on all grants (the two match).
Funding over time
peak $3.9M · FY2016–21$5M$3.8M$2.5M$1.3M$0
'16
'17
'18
'19
'20
'21
Funding mix
By agency
NIH$7,016,884 · 1
By mechanism
N01$7,016,884 · 1
Top collaborators
No co-investigators on record.
Most similar at International Aids Vaccine Initiative
Same institution · by research overlap
- Thomas Hassell$19,768,729
- Simon Hoffenberg$567,854
- Christopher Parks$4,922,886
- Ivo C Lorenz$1,014,926
- Michael J Caulfield$69,906
Others in their field
Top investigators on “Vaccine Development”
- Lawrence Corey · Fred Hutchinson Cancer Center$718,120,301
- Margaret Juliana McElrath · Fred Hutchinson Cancer Center$554,939,981
- Bambra Strokes · Ppd Development Lp$526,656,217
- Barton F Haynes · Duke University$394,383,754
- Glenda E Gray · Wits Health Consortium (Pty), Ltd$392,263,550
- Dennis R. Burton · Scripps Research Institute$312,611,400
Research focus
Vaccine DevelopmentContractsPreventImmunologyAssay DevelopmentInvestigational New Drug ApplicationNational Institute Of Allergy And Infectious DiseaseMolecular BiologyProteinsVaccinesProduct DevelopmentNovel VaccinesBasic ScienceChemistryHiv InfectionsClinicManufacturing Process DevelopmentClinical TrialsHiv VaccineBaseEnv Gene ProductsFormulationHiv-1Development Plans
Grant awards (11)
Nanoparticle-based Development for HIV-1 Biomolecule Delivery$69,352
N01 · FY2021 · AI · contact PI
Process Development for Cell Culture, Upstream and Downstream Process in Production of HIV-1 Biomolecules$1,726,828
N01 · FY2019 · AI · contact PI
Antigen-Adjuvant Formulation and Characterization Studies$1,072,626
N01 · FY2019 · AI · contact PI
NANOPARTICLE-BASED DEVELOPMENT FOR HIV-1 BIOMOLECULE DELIVERY$644,554
N01 · FY2019 · AI · contact PI
NIAID Process Development and Analytical Support for Development of HIV Vaccines$457,658
N01 · FY2019 · AI · contact PI
PURIFICATION OF HIV ENV PROTEINS WITH AN IMMUNOAFFINITY BASED PROCESS$897,313
N01 · FY2017 · AI · contact PI
Feasibility Assessment of HIV Env Protein Antigens$450,419
N01 · FY2017 · AI · contact PI
Product Development Plans to Support HIV Vaccine Manufacturing Efforts$135,934
N01 · FY2017 · AI · contact PI
Product Development Plans to Support HIV Vaccine Manufacturing Efforts$135,934
N01 · FY2017 · AI · contact PI
IGF::OT::IGF PURIFICATION OF HIV ENV PROTEINS WITH AN IMMUNOAFFINITY BASED PROCESS$772,238
N01 · FY2016 · AI · contact PI
IGF::OT::IGF ANALYSIS OF HIV-1 ENV HOST CELL PROTEINS BY MASS SPECTROMETRY METHOD$654,028
N01 · FY2016 · AI · contact PI